66 related articles for article (PubMed ID: 38468443)
1. Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors.
Joshi P; Ayyagari V; Kandel S; Modur V; Iqbal MF; Robinson K; Gao J; Rao K
Biomed Res Int; 2024; 2024():8544837. PubMed ID: 38803515
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
Vincent A; Krishnakumar S; Parameswaran S
Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma Protein Paralogs and Tumor Suppression.
Flores M; Goodrich DW
Front Genet; 2022; 13():818719. PubMed ID: 35368709
[TBL] [Abstract][Full Text] [Related]
4. Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies.
Janostiak R; Torres-Sanchez A; Posas F; de Nadal E
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267571
[TBL] [Abstract][Full Text] [Related]
5. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects.
Elahi AH; Morales CS; Xu XL; Eliades A; Patsalis PC; Abramson DH; Jhanwar SC
Adv Biol Regul; 2023 May; 88():100964. PubMed ID: 37004354
[TBL] [Abstract][Full Text] [Related]
6. RB1 loss induces quiescent state through downregulation of RAS signaling in mammary epithelial cells.
Gong L; Voon DC; Nakayama J; Takahashi C; Kohno S
Cancer Sci; 2024 May; 115(5):1576-1586. PubMed ID: 38468443
[TBL] [Abstract][Full Text] [Related]
7. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
J Biol Chem; 2014 Feb; 289(7):4116-25. PubMed ID: 24371144
[TBL] [Abstract][Full Text] [Related]
8. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.
Enrico TP; Stallaert W; Wick ET; Ngoi P; Wang X; Rubin SM; Brown NG; Purvis JE; Emanuele MJ
Elife; 2021 Dec; 10():. PubMed ID: 34851822
[TBL] [Abstract][Full Text] [Related]
9. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
[TBL] [Abstract][Full Text] [Related]
10. High incidence of allelic loss at 16q12.2 region spanning RBL2/p130 gene in retinoblastoma.
Priya K; Jada SR; Quah BL; Quah TC; Lai PS
Cancer Biol Ther; 2009 Apr; 8(8):714-7. PubMed ID: 19252413
[TBL] [Abstract][Full Text] [Related]
11. Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells.
Alessio N; Bohn W; Rauchberger V; Rizzolio F; Cipollaro M; Rosemann M; Irmler M; Beckers J; Giordano A; Galderisi U
Cell Mol Life Sci; 2013 May; 70(9):1637-51. PubMed ID: 23370776
[TBL] [Abstract][Full Text] [Related]
12. The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response.
Schuhwerk H; Kleemann J; Gupta P; van Roey R; Armstark I; Kreileder M; Feldker N; Ramesh V; Hajjaj Y; Fuchs K; Mahapatro M; Hribersek M; Volante M; Groenewoud A; Engel FB; Ceppi P; Eckstein M; Hartmann A; Müller F; Kroll T; Stemmler MP; Brabletz S; Brabletz T
Cell Rep; 2022 Dec; 41(11):111819. PubMed ID: 36516781
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy.
Sheng J; Kohno S; Okada N; Okahashi N; Teranishi K; Matsuda F; Shimizu H; Linn P; Nagatani N; Yamamura M; Harada K; Horike SI; Inoue H; Yano S; Kumar S; Kitajima S; Ajioka I; Takahashi C
Hepatology; 2021 Oct; 74(4):1971-1993. PubMed ID: 33931882
[TBL] [Abstract][Full Text] [Related]
14. Cellular Mechanisms and Regulation of Quiescence.
Marescal O; Cheeseman IM
Dev Cell; 2020 Nov; 55(3):259-271. PubMed ID: 33171109
[TBL] [Abstract][Full Text] [Related]
15. ERK signalling: a master regulator of cell behaviour, life and fate.
Lavoie H; Gagnon J; Therrien M
Nat Rev Mol Cell Biol; 2020 Oct; 21(10):607-632. PubMed ID: 32576977
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
